---
title: "Rifampin Injection Shortage Update: Current Availability and Manufacturer Information"
summary: "Rifampin Injection, an anti-infective medication, remains on the FDA drug shortage list. While the status is current, major manufacturers report that supplies are presently available."
category: "drug-shortages"
tags: ["drug-shortage","fda","medication","Rifampin","Injection"]
location: "United States"
severity: "low"
sourceUrl: "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
sourceAgency: "FDA"
publishedAt: 2026-02-11T19:16:24.000Z
---
## What's in Shortage
Rifampin Injection (Brand Name: RIFAMPIN) is currently listed in a shortage status by the FDA. This medication is classified as an anti-infective and is provided in an injection dosage form (600 mg).

## Which Manufacturers Are Affected
The following manufacturers are currently listed in the FDA database regarding the supply of Rifampin Injection:

*   **Mylan Institutional, a Viatris Company**
    *   **Status:** Available
    *   **Presentation:** Rifampin, Injection, 600 mg/10 mL (NDC 67457-445-60)
    *   **Contact:** 800-796-9526

*   **Fresenius Kabi USA, LLC**
    *   **Status:** Available
    *   **Presentation:** Rifampin, Injection, 600 mg (NDC 63323-351-20)
    *   **Note:** The manufacturer suggests checking with wholesalers for current inventory.
    *   **Contact:** 888-386-1300

## Why There's a Shortage
The FDA source data does not provide a specific reason for the current shortage status of Rifampin Injection.

## What Patients Should Do
If you or a loved one are prescribed Rifampin Injection, please consider the following practical steps:
*   **Consult Your Healthcare Provider:** Always discuss your treatment plan and any concerns regarding medication availability with your doctor.
*   **Speak with a Pharmacist:** Clinical or hospital pharmacists can provide the most up-to-date information regarding their specific facility's inventory.
*   **Contact Manufacturers:** You may use the contact numbers provided above to inquire about supply distribution and availability in your area.

*Disclaimer: This article is for informational purposes only and does not constitute medical advice. Patients should always consult with their healthcare provider or pharmacist regarding medical treatments and alternatives.*

## Source
Information provided by the FDA Drug Shortage Database.
*   **Initial Posting Date:** 02/17/2021
*   **Last Updated:** 02/05/2026